BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 10557621)

  • 1. Agency information collection activities; announcement of OMB approval; medical devices: third-party review program under the U.S./EC MRA. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Mar; 64(44):11018. PubMed ID: 10557621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical devices; implementation of third party review under the Food and Drug Administration Modernization Act of 1997; emergency processing request under OMB review--FDA. Notice.
    Fed Regist; 1998 May; 63(99):28388-91. PubMed ID: 10179874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agency information collection activities; announcement of OMB approval; Food Labeling: Nutrition Labeling of Dietary Supplements on a "Per Day" Basis. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Mar; 64(57):14451. PubMed ID: 10558410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical devices; reports of corrections and removals; lift of stay of effective date--FDA. Final rule; lift of stay of effective date.
    Fed Regist; 1998 Apr; 63(73):18836. PubMed ID: 10179315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of the mutual recognition agreement between the United States and the European Community; pharmaceutical GMP's and medical devices; establishment of a public docket and FDA contact points. Food and Drug Administration, HHS. Establishment of a public docket and FDA contact points.
    Fed Regist; 1999 Mar; 64(45):11376-7. PubMed ID: 10557625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunology and Microbiology Devices; Classification of Anti-Saccharomyces cerevisiae (S. cerevisiae) Antibody (ASCA) Test Systems. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Nov; 65(226):70305-7. PubMed ID: 11503713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical devices; ear, nose and throat devices; reclassification of the endolymphatic shunt tube with valve. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Apr; 67(82):20893-4. PubMed ID: 11980454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroenterology-urology devices; effective date of requirement for premarket approval of the penile inflatable implant. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(71):19650-8. PubMed ID: 11010632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroenterology and urology devices; effective date of requirement for premarket approval of the implanted mechanical/hydraulic urinary continence device. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Sep; 65(187):57726-32. PubMed ID: 11503643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical devices; gastroenterology-urology devices; nonimplanted, peripheral electrical continence device. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(68):18236-7. PubMed ID: 11010624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices), guidance for FDA reviewers and industry; availability--FDA. Notice.
    Fed Regist; 1998 Nov; 63(215):60009-10. PubMed ID: 10187389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Draft guidance for industry; exports and imports under the FDA Export Reform and Enhancement Act of 1996--FDA. Notice.
    Fed Regist; 1998 Jun; 63(113):32219-34. PubMed ID: 10180275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA Modernization Act of 1997: modifications to the list of recognized standards; availability; withdrawal of draft guidance "Use of IEC 60601 standards; medical electrical equipment"--FDA. Notice.
    Fed Regist; 1998 Oct; 63(200):55617-30. PubMed ID: 10185835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Final rule.
    Fed Regist; 1998 Oct; 63(195):54042-4. PubMed ID: 10185825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approval of an alternative requirement of the Mammography Quality Standards Act; availability--FDA. Notice.
    Fed Regist; 1998 Nov; 63(216 Pt 1):60352. PubMed ID: 10187394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical chemistry and clinical toxicology devices; classification of B-type natriuretic peptide test system. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2001 Feb; 66(40):12733-4. PubMed ID: 11503864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical devices; reclassification and codification of the stainless steel suture. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(72):19835-6. PubMed ID: 11010635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medtronic, Inc.; premarket approval of the Interstim Sacral Nerve Stimulation (SNS) System--FDA. Notice.
    Fed Regist; 1998 Jan; 63(19):4457. PubMed ID: 10177327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical devices; ear, nose, and throat devices; classification of the transcutaneous air conduction hearing aid system. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Nov; 67(216):67789-90. PubMed ID: 12422884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.